Sapu Bioscience
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10840 Thornmint Rd Ste 118, San Diego, C...Phone Number
(650) 635-7018Website
www.sapubio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sapu Bioscience
Sapu Bioscience is an immuno-oncology company focused on developing first-in-class RNA therapeutics and small molecule drugs targeting cancer and infectious diseases. Their lead candidate, OT-101, is an anti-TGF-β RNA therapeutic that has shown promise in treating relapsed/refractory cancer patients and has activity against SARS-CoV-2. The company aims to enhance treatment outcomes for cancer patients, particularly in rare pediatric cancers, and holds a rare pediatric designation for DIPG. With over 30 years of experience and more than 100 patent applications, Sapu Bioscience is positioned to make significant advancements in the field.Explore more
Sapu Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sapu Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Sapu Bioscience is spiking on competitors!
Product Launch: Get notified when Sapu Bioscience launches new products
Funding: Get notified immidiatlly once Sapu Bioscience has new funding data
Check if Sapu Bioscience has recently received funding, and reach out quickly before it becomes old news!
Sapu Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sapu Bioscience recently announced quarterly report
Click to see if Sapu Bioscience had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Sapu Bioscience
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Sapu Bioscience as Masked Content
Find 2 more new buyers
Compare Similar Companies to Sapu Bioscience
Compare insights from companies similar to Sapu Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sapu Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sapu Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sapu Bioscience.
Sapu Bioscience Tech Stack
A closer look at the technologies used by Sapu Bioscience
See more technologies
Sapu Bioscience News & Media
Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001
San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sapu BioScience today announced the publication of a new peer-reviewed study in the International Journal of Molecular Sciences that strengthens the scientific foundation for biomarker-guided taxane therapy and underscores the company’s long-standing leadership in transforming growth factor-beta 2 (TGFB2) biology.SAPU Bioscience Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
Data supports further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sapu Bioscience
Sign Up For FreeTo access detailed company insights
Sapu Bioscience is an immuno-oncology company focused on developing first-in-class RNA therapeutics and small molecule drugs targeting cancer and infectious diseases. Their lead candidate, OT-101, is an anti-TGF-β RNA therapeutic that has shown promise in treating relapsed/refractory cancer patients and has activity against SARS-CoV-2. The company... Read More
